Authors/Disclosures
|
Stephen H. Landy, MD, FAAN
|
Dr. Landy has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie, Amgen, Biohaven, Lilly, Lundbeck, Teva. |
|
Angela M. Hawkins, RN
(Saint Lukes Health System)
|
No disclosure on file |
|
Timothy R. Smith, MD
(Studymetrix Research, LLC)
|
The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vorso/Nesos. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder/Lundbeck. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurolief. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nocira. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. The institution of Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Smith has stock in United Health Group. The institution of Dr. Smith has received research support from Aeon. The institution of Dr. Smith has received research support from Alder/Lundbeck. The institution of Dr. Smith has received research support from Alnylam. The institution of Dr. Smith has received research support from Amgen. The institution of Dr. Smith has received research support from Abbvie/Allergan. The institution of Dr. Smith has received research support from Biohaven. The institution of an immediate family member of Dr. Smith has received research support from Eliem Pharmaceuticals. The institution of Dr. Smith has received research support from Lilly. The institution of Dr. Smith has received research support from Pfizer. The institution of Dr. Smith has received research support from Nocira. The institution of Dr. Smith has received research support from Novo Nordisk. The institution of Dr. Smith has received research support from Teva. The institution of Dr. Smith has received research support from Theranica. The institution of Dr. Smith has received research support from Vorso/Nesos. Dr. Smith has a non-compensated relationship as a Board Member with National Headache Foundation that is relevant to AAN interests or activities. |
|
Shuhan Zhu, MD
|
Dr. Zhu has nothing to disclose. |
|
Karin E. Olds, MD
(SLMBNI)
|
Dr. Olds has nothing to disclose. |
|
Stefan Dukic
(Trinity College Dublin)
|
No disclosure on file |
|
Merle Diamond
|
Merle Diamond has received personal compensation for serving as an employee of Diamond Headache Clinic. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Merle Diamond has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Merle Diamond has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie . Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome Therapeutics. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel Neuropharma. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal Pharmaceuticals'. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals Industries Ltd. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Axsome Pharma. Merle Diamond has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie . Merle Diamond has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel Neuropharma. Merle Diamond has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Pharmautical Industries Ltd. Merle Diamond has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck . Merle Diamond has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Headache Foundation . |
|
Coleman Martin, MD
|
Dr. Martin has nothing to disclose. |
|
Alan M. Rapoport, MD, FAAN
|
Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie, Amgen, Biohaven, Cala Health, Satsuma, Teva Pharmaceutical Industries, Theranica, Xoc and Zosano. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Amgen, Biohaven, Lundbeck and Teva Pharmaceutical Industries. Dr. Rapoport has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Reviews. |
|
Harold H. Morris III, MD, FAAN
(Saint Lukes Neurological Consultants)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Steven P. Burch, PhD
|
No disclosure on file |
|
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN
(Trinity Biomedical Sciences Institute)
|
Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB. |